Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q3 FY23 results · Oct–Dec 2022
Acutaas Chemicals reported revenue from operations of ₹152.36 crore (up 7.9% from Q3 FY22) and net profit of ₹22.28 crore (up 14.4% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 152.36 | 141.15 | +7.9% | 146.99 | +3.7% |
| Other income | 3.02 | 1.39 | +117.1% | 0.85 | +253.6% |
| Total income | 155.38 | 142.54 | +9.0% | 147.84 | +5.1% |
| Profit before tax | 29.57 | 28.56 | +3.5% | 25.71 | +15.0% |
| Net profit for the period | 22.28 | 19.47 | +14.4% | 19.04 | +17.0% |
| EPS, basic (₹) | 6.28 | 5.69 | +10.4% | 5.50 | +14.2% |
| Net margin (%) | 14.6 | 13.8 | 13.0 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 152.36 | 141.15 | +7.9% | 146.99 | +3.7% |
| Other income | 3.02 | 1.39 | +117.0% | 0.85 | +253.4% |
| Total income | 155.38 | 142.54 | +9.0% | 147.84 | +5.1% |
| Profit before tax | 29.57 | 28.56 | +3.5% | 25.71 | +15.0% |
| Net profit for the period | 22.28 | 19.47 | +14.4% | 19.04 | +17.0% |
| EPS, basic (₹) | 6.12 | 5.69 | +7.5% | 5.18 | +18.1% |
| Net margin (%) | 14.6 | 13.8 | 13.0 |
Consolidated
- Filed with BSE
- 06 Feb 2023, 14:31 IST
- Board meeting
- 04 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Feb 2023, 14:31 IST
- Board meeting
- 04 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE